ANTHONY INMON: Open Payments
NPI 1972055606 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 46 payments from 17 companies in 2025. Trend: 2023 $1,837 · 2024 $2,224 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $172 |
| PFIZER INC. | 10 | $137 |
| EMD Serono, Inc. | 2 | $105 |
| UCB, Inc. | 4 | $89 |
| Lilly USA, LLC | 4 | $79 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Biogen, Inc. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| ARGENX US, INC. | 2 | $40 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
Products named: NURTEC ODT, QULIPTA, Rystiggo, KISUNLA, KESIMPTA, VUMERITY, REXULTI, BOTOX.
Industry payments across MO — which companies pay providers there.
